# The Technology That Will Change Humans Forever

- Channel: [Nick Norwitz MD PhD](https://www.youtube.com/channel/UCLTZUJSEulehPtF_ytFiU_A)
- Published: 2026-06-01
- Source video: [Watch on YouTube](https://youtube.com/watch?v=eJTqiMsZP8Y)
- Read on ReadTube: https://www.read.tube/p/videos/eJTqiMsZP8Y
- Language: Original (source language)

## Summary

**Human Enhancement Nears Reality**

The video argues that human enhancement is moving from comic-book fantasy into real medicine through drugs, gene editing, cellular reprogramming, and mitochondrial therapy. It highlights phase-two obesity data for bimagrumab, CRISPR success in sickle cell disease, emerging prime editing for Alzheimer’s risk, and partial reprogramming as the basis for future anti-aging treatments.

The video frames modern biotechnology as the beginning of a real-life superhuman era, with innovations that can change body composition, correct inherited disease, and potentially slow or reverse aging. It starts with obesity treatments and argues that the next step beyond GLP-1 drugs is a therapy that reduces fat without sacrificing muscle. A phase-two trial of bimagrumab is presented as a major proof of concept because participants lost fat, gained muscle, and improved strength, suggesting that body composition can be engineered more directly than before.

From there, the video moves into gene editing. It explains CRISPR-Cas9 as molecular scissors and uses the FDA-approved sickle cell therapy as the clearest example of a genetic disease being corrected at its source. It then presents prime editing as a more precise search-and-replace tool that could one day address single-letter mutations in diseases including Alzheimer’s, especially by rewriting APOE4 risk variants toward protective forms, though delivery to the brain remains a major obstacle.

The final sections widen the scope from editing genes to resetting cells and signaling across the body. Partial reprogramming with Yamanaka factors is described as a way to restore younger epigenetic states without erasing cell identity, with preclinical work suggesting benefits for aging and progeria. The video also covers microRNAs as therapeutic messengers and mitochondria as transferrable power units that may eventually be produced externally and infused into patients. Overall, it argues that the limiting factor is increasingly not whether these therapies are possible, but how quickly they can be made safe, affordable, and widely available.

- GLP-1 drugs are effective but often cause unwanted muscle loss.
- Bimagrumab may selectively reduce fat while increasing muscle and strength.
- CRISPR has already cured many sickle cell patients in early trials.
- Prime editing could offer more precise correction for single-gene diseases.
- Alzheimer’s prevention may eventually come from editing APOE risk genes.
- Partial reprogramming may rejuvenate cells without turning them cancerous.
- MicroRNAs and mitochondria are emerging as additional tools for tissue repair and metabolic control.
- The core message is that human enhancement is becoming an engineering problem, not a fantasy.